34 related articles for article (PubMed ID: 38547391)
1. Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors.
Bansil S; Silva A; Taniguchi A; Wiedmer C; Fernandez M; Pagano I; Vierkoetter K; Killeen J; Fukui J
Oncologist; 2023 Feb; 28(2):116-122. PubMed ID: 36495151
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry.
Ransohoff JD; Miller I; Koo J; Joshi V; Kurian AW; Allison KH; John EM; Telli ML
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38547391
[TBL] [Abstract][Full Text] [Related]
3. Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Kolberg-Liedtke C; Feuerhake F; Garke M; Christgen M; Kates R; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Kuemmel S; Wuerstlein R; Graeser M; Nitz U; Kreipe H; Gluz O; Harbeck N
Breast Cancer Res; 2022 Sep; 24(1):58. PubMed ID: 36056374
[TBL] [Abstract][Full Text] [Related]
4. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
5. Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Floris G; Richard F; Hamy AS; Jongen L; Wildiers H; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; De Croze D; Meseure D; Salomon A; Laé M; Reyal F; Biganzoli E; Neven P; Desmedt C
J Natl Cancer Inst; 2021 Feb; 113(2):146-153. PubMed ID: 33152071
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.
Van Berckelaer C; Rypens C; van Dam P; Pouillon L; Parizel M; Schats KA; Kockx M; Tjalma WAA; Vermeulen P; van Laere S; Bertucci F; Colpaert C; Dirix L
Breast Cancer Res; 2019 Feb; 21(1):28. PubMed ID: 30777104
[TBL] [Abstract][Full Text] [Related]
7. The Role of Stromal Tumour Infiltrating Lymphocytes (sTIL) Intensity and Programmed Death Ligand 1 () Expression in Breast Cancer Response to Neoadjuvant Therapy in Cipto Mangunkusumo Hospital (CMH), Indonesia.
Rustamadji P; Felicia D; Wuyung PE; Hellyanti T
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3459-3465. PubMed ID: 37898851
[TBL] [Abstract][Full Text] [Related]
8. Allostatic load: a framework to understand breast cancer outcomes in Black women.
Obeng-Gyasi S; Tarver W; Carlos RC; Andersen BL
NPJ Breast Cancer; 2021 Jul; 7(1):100. PubMed ID: 34330927
[No Abstract] [Full Text] [Related]
9. Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.
Yao S; Cheng TD; Elkhanany A; Yan L; Omilian A; Abrams SI; Evans S; Hong CC; Qi Q; Davis W; Liu S; Bandera EV; Odunsi K; Takabe K; Khoury T; Ambrosone CB
J Natl Cancer Inst; 2021 Aug; 113(8):1036-1043. PubMed ID: 33395700
[TBL] [Abstract][Full Text] [Related]
10. Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P; Cortes J; Pusztai L; McArthur H; Kümmel S; Bergh J; Denkert C; Park YH; Hui R; Harbeck N; Takahashi M; Foukakis T; Fasching PA; Cardoso F; Untch M; Jia L; Karantza V; Zhao J; Aktan G; Dent R; O'Shaughnessy J;
N Engl J Med; 2020 Feb; 382(9):810-821. PubMed ID: 32101663
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer statistics, 2019.
DeSantis CE; Ma J; Gaudet MM; Newman LA; Miller KD; Goding Sauer A; Jemal A; Siegel RL
CA Cancer J Clin; 2019 Nov; 69(6):438-451. PubMed ID: 31577379
[TBL] [Abstract][Full Text] [Related]
12. Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study.
Reeder-Hayes KE; Mayer SE; Olshan AF; Wheeler SB; Carey LA; Tse CK; Bell ME; Troester MA
Cancer; 2019 Nov; 125(22):3985-3992. PubMed ID: 31398265
[TBL] [Abstract][Full Text] [Related]
13. Enrollment and biospecimen collection in a multiethnic family cohort: the Northern California site of the Breast Cancer Family Registry.
John EM; Sangaramoorthy M; Koo J; Whittemore AS; West DW
Cancer Causes Control; 2019 Apr; 30(4):395-408. PubMed ID: 30835011
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
Loi S; Drubay D; Adams S; Pruneri G; Francis PA; Lacroix-Triki M; Joensuu H; Dieci MV; Badve S; Demaria S; Gray R; Munzone E; Lemonnier J; Sotiriou C; Piccart MJ; Kellokumpu-Lehtinen PL; Vingiani A; Gray K; Andre F; Denkert C; Salgado R; Michiels S
J Clin Oncol; 2019 Mar; 37(7):559-569. PubMed ID: 30650045
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
